MGX logo

Metagenomi, Inc. Common Stock

MGX
Healthcare|Biotechnology|US
$0.71
-0.02 (-2.93%)
Tangible Book / Share
$2.99
Cash / Share
$3.20

Ownership Breakdown

67.6%
Float
37.8M
Shares Outstanding
25.5M
Float Shares

Major Holders (1)

Combined: 7.3%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Thomas Brian C.Individual7.30%2,762,142Sep 10, 202613D/G

Insider Trades (100)

Last 4 quarters: 1,358,900 acquired · 250,927 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Reid LaurencedirectorSep 9, 2026BUY117$1.18$138.06Form 4
Reid LaurencedirectorSep 9, 2026BUY19,883$1.17$23.3KForm 4
Wein MatthewSee RemarksSep 8, 2026SELL358$1.16$414.71Form 4
Irish Jiandirector, officer: See RemarksSep 8, 2026SELL2,140$1.16$2.5KForm 4
Wapnick PamelaChief Financial OfficerSep 8, 2026SELL1,911$1.16$2.2KForm 4
Reid LaurencedirectorJun 9, 2026AWARD17,400$1.23$21.4KForm 4
Dere Willard HdirectorJun 9, 2026AWARD21,000$1.23$25.8KForm 4
BJERKHOLT ERICdirectorJun 9, 2026AWARD21,000$1.23$25.8KForm 4
Eckhardt JuergendirectorJun 9, 2026AWARD21,000$1.23$25.8KForm 4
Wapnick PamelaChief Financial OfficerJun 5, 2026SELL2,884$1.30$3.7KForm 4
Irish Jiandirector, officer: See RemarksJun 5, 2026SELL3,737$1.30$4.9KForm 4
Wein MatthewSee RemarksJun 5, 2026SELL558$1.30$724.84Form 4
Irish Jiandirector, officer: See RemarksApr 1, 2026AWARD46,000——Form 4
Irish Jiandirector, officer: See RemarksApr 1, 2026AWARD276,000$1.34$369.8KForm 4
Wein MatthewSee RemarksApr 1, 2026AWARD11,000——Form 4
Wein MatthewSee RemarksApr 1, 2026AWARD68,000$1.34$91.1KForm 4
Wapnick PamelaChief Financial OfficerApr 1, 2026AWARD24,000——Form 4
Wapnick PamelaChief Financial OfficerApr 1, 2026AWARD144,000$1.34$193.0KForm 4
Wapnick PamelaChief Financial OfficerMar 5, 2026SELL1,581$1.60$2.5KForm 4
Wein MatthewSee RemarksMar 5, 2026SELL482$1.60$771.20Form 4
Irish Jiandirector, officer: Chief Executive OfficerDec 5, 2025GIFT228,462——Form 4
Irish Jiandirector, officer: Chief Executive OfficerMar 5, 2026SELL1,607$1.60$2.6KForm 4
Thomas Brian C.directorDec 5, 2025SELL3,830$1.77$6.8KForm 4
Wein MatthewSee RemarksDec 5, 2025SELL199$1.77$352.61Form 4
Wapnick PamelaChief Financial OfficerDec 5, 2025SELL1,576$1.77$2.8KForm 4
Irish Jiandirector, officer: Chief Executive OfficerDec 5, 2025SELL1,602$1.77$2.8KForm 4
Thomas Brian C.directorSep 5, 2025SELL2,701$1.81$4.9KForm 4
Wapnick PamelaChief Financial OfficerDec 1, 2025AWARD120,000$1.60$192.0KForm 4
Wapnick PamelaChief Financial OfficerSep 5, 2025SELL1,576$1.81$2.9KForm 4
Irish Jiandirector, officer: Chief Executive OfficerDec 1, 2025AWARD211,000$1.60$337.6KForm 4
Irish Jiandirector, officer: Chief Executive OfficerDec 1, 2025AWARD37,500$1.60$60.0KForm 4
Irish Jiandirector, officer: Chief Executive OfficerSep 5, 2025SELL1,602$1.81$2.9KForm 4
Irish Jiandirector, officer: Chief Executive OfficerDec 1, 2025AWARD225,000$1.60$360.0KForm 4
Wein MatthewSee RemarksDec 1, 2025AWARD96,000$1.60$153.6KForm 4
Wein MatthewSee RemarksSep 5, 2025SELL199$1.81$360.19Form 4
Reid LaurencedirectorSep 2, 2025AWARD42,000$1.82$76.4KForm 4
Reid LaurenceAug 11, 2025OTHER0——Form 4
Eckhardt JuergendirectorJun 10, 2025AWARD21,000$1.57$33.0KForm 4
Dere Willard HdirectorJun 10, 2025AWARD21,000$1.57$33.0KForm 4
BJERKHOLT ERICdirectorJun 10, 2025AWARD8,572$1.57$13.5KForm 4
Wein MatthewSee RemarksJun 6, 2025SELL199$1.75$348.25Form 4
Noonberg Sarah B.Chief Medical OfficerJun 6, 2025SELL5,239$1.75$9.2KForm 4
Wapnick PamelaChief Financial OfficerJun 6, 2025SELL1,576$1.75$2.8KForm 4
Thomas Brian C.director, officer: Chief Executive OfficerJun 6, 2025SELL10,785$1.75$18.9KForm 4
Irish Jiandirector, officer: See RemarksJun 6, 2025SELL6,390$1.75$11.2KForm 4
Wapnick PamelaChief Financial OfficerApr 1, 2025AWARD84,000$1.32$110.9KForm 4
Wapnick PamelaChief Financial OfficerApr 1, 2025AWARD14,000——Form 4
Thomas Brian C.director, officer: Chief Executive OfficerApr 1, 2025AWARD32,000——Form 4
Thomas Brian C.director, officer: Chief Executive OfficerApr 1, 2025AWARD196,000$1.32$258.7KForm 4
Irish Jiandirector, officer: See RemarksApr 1, 2025AWARD23,000——Form 4
Irish Jiandirector, officer: See RemarksApr 1, 2025AWARD140,000$1.32$184.8KForm 4
Wein MatthewSee RemarksApr 1, 2025AWARD22,725$1.32$30.0KForm 4
Wein MatthewSee RemarksApr 1, 2025AWARD21,875$1.32$28.9KForm 4
Wein MatthewSee RemarksApr 1, 2025AWARD3,775——Form 4
Wein MatthewSee RemarksApr 1, 2025AWARD3,650——Form 4
Noonberg Sarah B.Chief Medical OfficerApr 1, 2025AWARD14,000——Form 4
Noonberg Sarah B.Chief Medical OfficerApr 1, 2025AWARD84,000$1.32$110.9KForm 4
Wein MatthewSee RemarksMar 5, 2025SELL930$1.87$1.7KForm 4
Wapnick PamelaChief Financial OfficerMar 5, 2025SELL1,808$1.87$3.4KForm 4
BJERKHOLT ERICdirectorFeb 3, 2025AWARD42,000$2.51$105.4KForm 4
BJERKHOLT ERICJan 27, 2025OTHER0——Form 4
Wapnick PamelaChief Financial OfficerDec 5, 2024SELL1,559$1.86$2.9KForm 4
Wapnick PamelaChief Financial OfficerSep 5, 2024SELL6,265$2.88$18.0KForm 4
Irish Jiandirector, officer: See RemarksApr 1, 2024AWARD70,471——Form 4
Irish Jiandirector, officer: See RemarksApr 1, 2024AWARD296,308$10.82$3.2MForm 4
Eckhardt JuergendirectorApr 1, 2024AWARD78,636$10.82$850.8KForm 4
Borges LuisChief Scientific OfficerApr 1, 2024AWARD291,450$10.82$3.2MForm 4
Borges LuisChief Scientific OfficerApr 1, 2024AWARD69,316——Form 4
Wein MatthewSee RemarksApr 1, 2024AWARD43,717$10.82$473.0KForm 4
Wein MatthewSee RemarksApr 1, 2024AWARD10,397——Form 4
Wapnick PamelaChief Financial OfficerApr 1, 2024AWARD291,450$10.82$3.2MForm 4
Wapnick PamelaChief Financial OfficerApr 1, 2024AWARD69,316——Form 4
Noonberg Sarah B.Chief Medical OfficerApr 1, 2024AWARD242,875$10.82$2.6MForm 4
Noonberg Sarah B.Chief Medical OfficerApr 1, 2024AWARD57,763——Form 4
Bernales SebastiandirectorApr 1, 2024AWARD78,636$10.82$850.8KForm 4
Harnest SimonSee RemarksApr 1, 2024AWARD11,552——Form 4
Harnest SimonSee RemarksApr 1, 2024AWARD48,575$10.82$525.6KForm 4
Delaney SimrenSee RemarksApr 1, 2024AWARD6,931——Form 4
Delaney SimrenSee RemarksApr 1, 2024AWARD29,145$10.82$315.3KForm 4
Dere Willard HdirectorApr 1, 2024AWARD78,636$10.82$850.8KForm 4
Thomas Brian C.director, officer: Chief Executive OfficerApr 1, 2024AWARD118,992——Form 4
Thomas Brian C.director, officer: Chief Executive OfficerApr 1, 2024AWARD500,323$10.82$5.4MForm 4
Novo Holdings A/S10 percent ownerFeb 13, 2024BUY800,000$15.00$12.0MForm 4
Novo Holdings A/S10 percent ownerFeb 13, 2024CONVERSION839,175——Form 4
Novo Holdings A/S10 percent ownerFeb 9, 2024BUY100,000$10.25$1.0MForm 4
Novo Holdings A/S10 percent ownerFeb 13, 2024CONVERSION691,760——Form 4
Novo Holdings A/S10 percent ownerFeb 13, 2024CONVERSION147,415——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 13, 2024CONVERSION509,855——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 13, 2024CONVERSION589,662——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 13, 2024CONVERSION1,180,592——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 13, 2024CONVERSION1,770,888——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 13, 2024CONVERSION2,062,387——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 13, 2024CONVERSION3,093,580——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 13, 2024CONVERSION1,030,086——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 13, 2024CONVERSION890,671——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 8, 2024OTHER1,770,888——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 8, 2024OTHER1,180,592——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 8, 2024OTHER589,662——Form 4
BAYER HEALTHCARE LLC10 percent ownerFeb 8, 2024OTHER509,855——Form 4
Bernales SebastiandirectorFeb 13, 2024CONVERSION1,896,445——Form 4